Labshake search
Citations for Leinco Technologies :
1 - 5 of 5 citations for 7 chloro 4 hydroxy 3 nitroquinoline since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... allowed to sit for 3 hours and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) for 4 hr ...
-
bioRxiv - Immunology 2022Quote: ... and 100 μg anti CTLA-4 (clone 9D9, Leinco Technologies) in volume of 200 μg 1X PBS.
-
bioRxiv - Immunology 2023Quote: ... and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) at a 40ng/ml concentration for 6 hours ...
-
bioRxiv - Immunology 2022Quote: ... Mice were also treated with 4 μg mIFNβ neutralising antibodies (Leinco Technologies Inc). Control groups were treated with either buffer or an IgG isotype control antibody equivalently.
-
bioRxiv - Immunology 2023Quote: ... they were treated with anti-PD-1 anti-CTLA-4 antibodies (clones RMP1-14 and 9H10, respectively, from Leinco Technologies Inc., Fenton, MO, USA): 200 µg ab/injection ...